FindTrial
Sign In

Therapeutic Efficacy and Underlying Mechanisms of Penetrating Needling from Qiuxu (GB40) to Zhaohai (KI6) for Post-Stroke Lower Limb Dysfunction.

Clinical Efficacy Verification and Mechanism Study of Acupuncture at Qiuxu (GB40) Penetrating Zhaohai (KI6) for Lower Extremity Dysfunction After Stroke

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000773
Enrollment
Unknown
Registered
2026-03-27
Start date
2026-03-31
Completion date
Unknown
Last updated
2026-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stroke

Interventions

experimental group:penetrating needling from Qiuxu (GB 40) to Zhaohai (KI 6)
control group:manual acupuncture at Qiuxu (GB 40) and Zhaohai (KI 6) with separate needle insertion

Sponsors

The First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Age 30–80 years; (2) In the subacute stroke phase, with onset time between 2 weeks and 6 months; (3) Presence of lower limb motor dysfunction; (4) Cognitive function sufficient to meet the requirements for study cooperation, with a Mini-Mental State Examination (MMSE) score = 24; (5) Native Chinese speaker; (6) Right-handed as determined by the Edinburgh Handedness Inventory; (7) Vital signs stable and able to cooperate in completing the study procedures; (8) The subject or their legal guardian provides informed consent and signs a written informed consent form.

Exclusion criteria

Exclusion criteria: (1) Subjects whom the investigator deems to have significant compliance issues and are unable to complete the study procedures; (2) Subjects who have received acupuncture treatment within the past week; (3) Subjects with a history of epileptic seizures, impaired consciousness, or increased intracranial pressure; (4) Subjects with severe lower limb spasticity or severe pain that would affect assessment or the implementation of the intervention; (5) Subjects with severe cardiac disease; (6) Female subjects who are pregnant, planning pregnancy, or are lactating; (7) Subjects with severe psychiatric disorders; (8) Other circumstances deemed by the investigator as inappropriate for inclusion.

Design outcomes

Primary

MeasureTime frame
Fugl-Meyer Assessment of Lower Extremity (FMA-LE);—

Secondary

MeasureTime frame
functional near-infrared spectroscopy (fNIRS);Manual Muscle Testing (MMT);Berg Balance Scale (BBS);Modified Ashworth Scale (MAS);surface electromyography (sEMG);—

Countries

China

Contacts

Public ContactZhangjie

The First Teaching Hospital of Tianjin University of Traditional Chinese Medicine

zhangjie6766@163.com15620836766

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Sep 12, 2026